Gelteq Limited (GELS)
NASDAQ: GELS · Real-Time Price · USD
1.080
+0.020 (1.89%)
At close: Nov 28, 2025, 1:00 PM EST
1.100
+0.020 (1.85%)
After-hours: Nov 28, 2025, 4:39 PM EST
Gelteq Employees
As of June 30, 2025, Gelteq had 8 total employees, including 7 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
8
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$33,857
Profits / Employee
-$544,602
Market Cap
11.57M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 8 | 0 | - |
| Jun 30, 2024 | 8 | 0 | - |
| Jun 30, 2023 | 8 | 5 | 166.67% |
| Jun 30, 2021 | 3 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
GELS News
- 5 days ago - Gelteq Announces Positive Preclinical Results Demonstrating Enhanced Bioavailability Using Its Proprietary Gel-Based Drug Delivery Platform - GlobeNewsWire
- 14 days ago - Healthy Extracts Reports Record Q3 2025, with Revenue up 23% - Accesswire
- 18 days ago - Nutraceutical Technology Leader, Healthy Extracts, Invited to Present at the Trickle Research Microcap Conference on November 13, 2025 - Accesswire
- 2 months ago - Gelteq Technology Powers U.S. Product Launches of its Nutraceutical Products for Partner - GlobeNewsWire
- 3 months ago - Gelteq Announces Commencement of Preclinical Trial for Novel Gel-Based Antihistamine Formulation Targeting Allergy Market - GlobeNewsWire
- 3 months ago - Healthy Extracts Builds Upon Record Q2 Results and Transformative Merger with Launch of New Revolutionary Hydration and Sugar Metabolism Gel-Packs - Accesswire
- 3 months ago - Healthy Extracts Reports Record Q2 2025 Net Revenue, Driving Positive EPS and EBITDA; Increases 2025 Net Revenue Guidance by 50% - Accesswire
- 4 months ago - Healthy Extracts Expects Record Sales for Q2 2025, Driving Strong Positive Adj. EBITDA - Accesswire